Cargando…
The discovery and characterization of K‐563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp
Keap1/Nrf2 pathway regulates the antioxidant stress response, detoxification response, and energy metabolism. Previous reports found that aberrant Keap1/Nrf2 pathway activation due to Kelch‐like ECH‐associated protein 1 (Keap1) mutations or Nuclear factor E2‐related factor 2 (Nrf2) mutations induced...
Autores principales: | Hori, Ran, Yamaguchi, Kozo, Sato, Hidetaka, Watanabe, Miwa, Tsutsumi, Kyoko, Iwamoto, Susumu, Abe, Masayuki, Onodera, Hideyuki, Nakamura, Satoshi, Nakai, Ryuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434342/ https://www.ncbi.nlm.nih.gov/pubmed/30735010 http://dx.doi.org/10.1002/cam4.1949 |
Ejemplares similares
-
Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma
por: Chen, Jiang, et al.
Publicado: (2016) -
The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017) -
Single-cell transcriptomics identifies Keap1-Nrf2 regulated collective invasion in a Drosophila tumor model
por: Chatterjee, Deeptiman, et al.
Publicado: (2022) -
PS 339-563
Publicado: (2005) -
The KEAP1-NRF2 System and Esophageal Cancer
por: Hirose, Wataru, et al.
Publicado: (2022)